GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Leadman Biochemistry Co Ltd (SZSE:300289) » Definitions » Scaled Net Operating Assets

Beijing Leadman Biochemistry Co (SZSE:300289) Scaled Net Operating Assets : 0.50 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Beijing Leadman Biochemistry Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Beijing Leadman Biochemistry Co's operating assets for the quarter that ended in Mar. 2024 was ¥1,058.8 Mil. Beijing Leadman Biochemistry Co's operating liabilities for the quarter that ended in Mar. 2024 was ¥95.0 Mil. Beijing Leadman Biochemistry Co's Total Assets for the quarter that ended in Dec. 2023 was ¥1,938.4 Mil. Therefore, Beijing Leadman Biochemistry Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.50.


Beijing Leadman Biochemistry Co Scaled Net Operating Assets Historical Data

The historical data trend for Beijing Leadman Biochemistry Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Leadman Biochemistry Co Scaled Net Operating Assets Chart

Beijing Leadman Biochemistry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.70 0.65 0.69 0.44 0.48

Beijing Leadman Biochemistry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.52 0.50 0.49 0.50

Competitive Comparison of Beijing Leadman Biochemistry Co's Scaled Net Operating Assets

For the Medical Devices subindustry, Beijing Leadman Biochemistry Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Leadman Biochemistry Co's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beijing Leadman Biochemistry Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Beijing Leadman Biochemistry Co's Scaled Net Operating Assets falls into.



Beijing Leadman Biochemistry Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Beijing Leadman Biochemistry Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(1083.084-124.823)/1999.821
=0.48

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1938.399 - 855.315
=1083.084

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=133.769 - 4.653 - 4.293
=124.823

Beijing Leadman Biochemistry Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(1058.811-95.009)/1938.399
=0.50

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1906.544 - 847.733
=1058.811

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=102.922 - 3.499 - 4.414
=95.009

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Leadman Biochemistry Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Beijing Leadman Biochemistry Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Leadman Biochemistry Co (SZSE:300289) Business Description

Traded in Other Exchanges
N/A
Address
No.5 Hongda South Road, Beijing, CHN
Beijing Leadman Biochemistry Co Ltd is a biotechnology company based in China. The company is focusing on research and development, manufacture, and sales of in vitro diagnostic (IVD) products. The company has core competencies in biochemistry, in vitro diagnostic reagents and instruments. Its product offering includes biochemical raw materials such as enzymes, coenzymes, antibodies, buffers, and enzyme substrates; biochemistry diagnostic and companion reagents; and medical test instruments.
Executives
Ding Yao Liang Executives
Wang Xiao Hong Supervisors
Zhang Hai Tao Executives
Zhang Ya Li Supervisors
Sun Qian Director
Wang Jian Hua Directors, executives
Wang Yi Xing Directors, executives
Yang Lu Ping Securities Affairs Representative
Niu Ju Hui Secretary Dong
Zhang Kun Director
Shen Guang Qian Directors, executives
Ma Yan Wen Director
Wang Lan Zhen Directors, executives

Beijing Leadman Biochemistry Co (SZSE:300289) Headlines

No Headlines